Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,590.21
(
-0.33%
)
US TECH 100
23,418.40
(
-0.52%
)
Dow Jones
46,451.10
(
-0.47%
)
Brent Oil
104.51
(
-2.40%
)
Bitcoin
69,005.25
(
0.21%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: peregrinus post# 115798

Monday, 03/11/2013 6:12:01 PM

Monday, March 11, 2013 6:12:01 PM

Post# of 347009
Good response back! Lets hope King mirrors these statements and gets everything out in the open tomorrow during the conference call.... and have Thorpe and Garnick available on the call to finally put the opposition ... out... of.... service.

-GLTA!

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote